Literature DB >> 36163384

Structural mechanisms of TRPV2 modulation by endogenous and exogenous ligands.

Nannan Su1,2,3, Wenxuan Zhen1,3, Heng Zhang1,3, Lingyi Xu2, Yitian Jin1, Xiaoying Chen1,3, Cheng Zhao2, Qinrui Wang4, Xinyan Wang4, Shaowei Li4, Han Wen5, Wei Yang6, Jiangtao Guo7,8, Fan Yang9,10,11.   

Abstract

The transient receptor potential vanilloid 2 (TRPV2) ion channel is a polymodal receptor widely involved in many physiological and pathological processes. Despite many TRPV2 modulators being identified, whether and how TRPV2 is regulated by endogenous lipids remains elusive. Here, we report an endogenous cholesterol molecule inside the vanilloid binding pocket (VBP) of TRPV2, with a 'head down, tail up' configuration, resolved at 3.2 Å using cryo-EM. Cholesterol binding antagonizes ligand activation of TRPV2, which is removed from VBP by methyl-β-cyclodextrin (MβCD) as resolved at 2.9 Å. We also observed that estradiol (E2) potentiated TRPV2 activation by 2-aminoethoxydiphenyl borate (2-APB), a classic tool compound for TRP channels. Our cryo-EM structures (resolved at 2.8-3.3 Å) further suggest how E2 disturbed cholesterol binding and how 2-APB bound within the VBP with E2 or without both E2 and endogenous cholesterol, respectively. Therefore, our study has established the structural basis for ligand recognition of the inhibitory endogenous cholesterol and excitatory exogenous 2-APB in TRPV2.
© 2022. The Author(s), under exclusive licence to Springer Nature America, Inc.

Entities:  

Year:  2022        PMID: 36163384     DOI: 10.1038/s41589-022-01139-8

Source DB:  PubMed          Journal:  Nat Chem Biol        ISSN: 1552-4450            Impact factor:   16.174


  56 in total

Review 1.  TRP channels and pain.

Authors:  David Julius
Journal:  Annu Rev Cell Dev Biol       Date:  2013       Impact factor: 13.827

Review 2.  The role of cholesterol in membrane fusion.

Authors:  Sung-Tae Yang; Alex J B Kreutzberger; Jinwoo Lee; Volker Kiessling; Lukas K Tamm
Journal:  Chem Phys Lipids       Date:  2016-05-11       Impact factor: 3.329

3.  Identification of a binding motif in the S5 helix that confers cholesterol sensitivity to the TRPV1 ion channel.

Authors:  Giovanni Picazo-Juárez; Silvina Romero-Suárez; Andrés Nieto-Posadas; Itzel Llorente; Andrés Jara-Oseguera; Margaret Briggs; Thomas J McIntosh; Sidney A Simon; Ernesto Ladrón-de-Guevara; León D Islas; Tamara Rosenbaum
Journal:  J Biol Chem       Date:  2011-05-09       Impact factor: 5.157

4.  The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1).

Authors:  D Smart; M J Gunthorpe; J C Jerman; S Nasir; J Gray; A I Muir; J K Chambers; A D Randall; J B Davis
Journal:  Br J Pharmacol       Date:  2000-01       Impact factor: 8.739

5.  Structural snapshots of TRPV1 reveal mechanism of polymodal functionality.

Authors:  Kaihua Zhang; David Julius; Yifan Cheng
Journal:  Cell       Date:  2021-09-07       Impact factor: 66.850

6.  Heat-dependent opening of TRPV1 in the presence of capsaicin.

Authors:  Do Hoon Kwon; Feng Zhang; Yang Suo; Jonathan Bouvette; Mario J Borgnia; Seok-Yong Lee
Journal:  Nat Struct Mol Biol       Date:  2021-07-08       Impact factor: 15.369

7.  Thermodynamics of heat activation of single capsaicin ion channels VR1.

Authors:  Beiying Liu; Kwokyin Hui; Feng Qin
Journal:  Biophys J       Date:  2003-11       Impact factor: 4.033

Review 8.  Cannabinoid Ligands Targeting TRP Channels.

Authors:  Chanté Muller; Paula Morales; Patricia H Reggio
Journal:  Front Mol Neurosci       Date:  2019-01-15       Impact factor: 5.639

9.  Extracellular cap domain is an essential component of the TRPV1 gating mechanism.

Authors:  Kirill D Nadezhdin; Arthur Neuberger; Yury A Nikolaev; Lyle A Murphy; Elena O Gracheva; Sviatoslav N Bagriantsev; Alexander I Sobolevsky
Journal:  Nat Commun       Date:  2021-04-12       Impact factor: 14.919

10.  TRPV1 structures in nanodiscs reveal mechanisms of ligand and lipid action.

Authors:  Yuan Gao; Erhu Cao; David Julius; Yifan Cheng
Journal:  Nature       Date:  2016-05-18       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.